Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
April 21, 2022 8:30 AM 7 min read

UPSIDE Foods Raises a $400M Series C Round to Commercialize Cultivated Meat at Scale

by PRNewswire
Follow

- This is the largest funding round in the cultivated meat industry to date, bringing UPSIDE's valuation to over $1 billion and accelerating its path to commercialization

- The round was co-led by Temasek and Abu Dhabi Growth Fund (ADG) and a broad coalition of financial, impact and strategic investors, reflecting growing global interest

- Funds will be focused on critical requirements for scale: building a commercial-scale facility, educating consumers, and developing the supply chain for cell feed (media) and other inputs

BERKELEY, Calif., April 21, 2022 /PRNewswire/ -- UPSIDE Foods (formerly Memphis Meats), the leading company in the cultivated meat, poultry, and seafood industry, has announced the close of a $400 million Series C funding round, the largest round in the industry to date. This new raise will help unlock the industry's biggest opportunities around scale and places the company's valuation at over $1 billion. Pending regulatory review, UPSIDE Foods plans to be available to consumers in the U.S. later this year.

"UPSIDE has reached an historic inflection point, moving from R&D to commercialization," said Dr. Uma Valeti, CEO and Founder of UPSIDE Foods. "Our team at UPSIDE continues to overcome seemingly insurmountable challenges in our mission to make our favorite food a force for good. Working in partnership with our world-class coalition of investors, we're excited to bring delicious, sustainable and humane meat to the consumers around the world."

"We're excited to support this next chapter of UPSIDE Foods' growth," said Brian Sikes, COO of Cargill. "Our continued support for UPSIDE's innovative work underscores Cargill's commitment to an inclusive approach to wholesome, sustainable protein that will meet customer and consumer needs now and in the future."

Media Contact
Brooke Whitney
[email protected]

SOURCE UPSIDE Foods

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
CommoditiesPress ReleasesVenture Capital
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter

UPSIDE Foods will use the funds to build a commercial production facility with a planned annual capacity of tens of millions of pounds of cultivated meat products. The facility will be able to produce any species of meat in both ground and whole cut formats, with an initial focus on chicken. Additionally, the funds will help build a robust supply chain for critical cell feed components that will reduce costs and enable greater scale. Other priorities for UPSIDE Foods include enhancing consumer education, investing in research and development for the next generation of cultivated meat products, and continuing to grow its 170+ person team.  

The Series C round is co-led by Temasek, a global investment company headquartered in Singapore, and the Abu Dhabi Growth Fund (ADG), a new investor. Other new investors include Baillie Gifford, Givaudan, John Doerr, SALT fund, and Synthesis Capital. They are joined by existing investors Bill Gates, Cargill,  Cercano Management, CPT Capital, Dentsu Ventures, Singapore-based global investor EDBI, Kimbal and Christiana Musk, Norwest Venture Partners, SoftBank Vision Fund 2, SOSV's Indie Bio, and Tyson Foods.

"Our approach is to identify and hold transformational growth companies with the potential to disrupt industries," said Chris Evdaimon from Baillie Gifford's Private Companies Team. "Cultivated meat is well on its way to becoming a large-scale industry. And UPSIDE Foods is a frontrunner in developing ways to both make and market the product. We believe it's a great long-term investment that will help the environment, animal welfare and the food system as a whole."

"As early supporters, we have been continually impressed to witness UPSIDE's consistent, and industry-leading, technical and commercial progress since their founding in 2015, " said Rosie Wardle, Co-Founder and Partner, Synthesis Capital. "The company's recent achievements have validated their position as the leading company in this sector. We are excited to continue backing and supporting UPSIDE to the next stage of commercial scale production, and to changing the food system for the better."

Since UPSIDE Foods announced its Series B in early 2020, the company has been at the forefront of the industry, driving product innovation, partnerships and scale. In the last year alone, it has rebranded from Memphis Meats to UPSIDE Foods, welcomed Whole Foods CEO John Mackey as an investor, announced chicken as its first consumer product, partnered with three-Michelin starred chef Dominique Crenn, developed a cell feed that's completely free of animal components, acquired cultivated seafood company Cultured Decadence, built and opened its Engineering, Production and Innovation Center (EPIC), the most advanced production facility and innovation center for cultivated meat in the world, and recently hosted its first public tour of EPIC as part of a broader effort to educate consumers about cultivated meat and UPSIDE Foods' mission and production process.

About UPSIDE Foods 
Based in Berkeley, CA, UPSIDE Foods (formerly known as Memphis Meats) is developing a way to grow real meat, poultry and seafood directly from animal cells, without the need to raise and slaughter animals. These products are not vegetarian, plant-based or meat alternatives -- they are real meat, made without the animal. Founded as the world's first cultivated meat company in 2015, UPSIDE Foods has achieved numerous industry-defining milestones, including being the first company to produce multiple species of meat (beef, chicken and duck). The company believes that people shouldn't have to choose between the foods they love and a thriving planet, and is working to build a better food system where everybody has access to delicious, humane, and sustainable meat. UPSIDE Foods has won various industry awards, including New York Times' Good Tech Awards, FastCo's Next Big Thing in Tech, and the Best and Brightest Companies to Work For in the Nation by the National Association for Business Resources. UPSIDE Foods has raised a total of $608 million. For more information, please visit www.upsidefoods.com.

About Temasek
Temasek is a global investment company with a net portfolio value of S$381 billion (US$283b) as at 31 March 2021. Headquartered in Singapore, it has 13 offices in 9 countries around the world. The Temasek Charter defines Temasek's three roles as an Investor, Institution and Steward, which shape its ethos to do well, do right, and do good. As a provider of catalytic capital, it seeks to enable solutions to key global challenges. With sustainability at the core of all Temasek does, it actively seeks sustainable solutions to address present and future challenges, as it captures investible opportunities to bring about a sustainable future for all. For more information on Temasek, please visit www.temasek.com.sg.

About Abu Dhabi Growth Fund
Abu Dhabi Growth Fund is a sovereign investment fund established in July 2021 with the mandate of pursuing a differentiated investment strategy to generate high financial returns  for its shareholder, the Abu Dhabi Government. A new sovereign investor, ADG has a unique risk profile that complements the existing Abu Dhabi sovereign wealth funds. In line with its fundamental mandate for growth, ADG  invests primarily in private equity, venture capital, hedge fund and public equities. We actively seek high-return opportunities by partnering with best-in-class fund managers and leading entrepreneurs and corporates across the world. ADG has an agile approach to investing, with a seasoned team that brings decades of successful investment experience and unique networks across asset classes, sectors and geographies.

Comments
Loading...